1. Home
  2. Insider Trading Stock Activity
  3. Schneider Eugene
Schneider Eugene

Schneider Eugene

EVP, Chf Clinical Develop Ofcr of IONS

Stock Insider Trading Activity of Schneider Eugene

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Jan 16, 2026

Avg Cost/Share

$75.59

Shares

9,302

Total Value

$703,138.18

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Sep 3, 2025

Avg Cost/Share

$60.94

Shares

39,316

Total Value

$2,390,841.75

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Jan 30, 2025

Avg Cost/Share

$32.20

Shares

1,484

Total Value

$47,779.90

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Jan 15, 2025

Avg Cost/Share

$32.79

Shares

6,523

Total Value

$213,889.17

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Feb 2, 2024

Avg Cost/Share

$49.59

Shares

2,106

Total Value

$104,436.54

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Feb 1, 2024

Avg Cost/Share

$49.59

Shares

2,071

Total Value

$102,700.89

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Jan 16, 2024

Avg Cost/Share

$50.42

Shares

5,482

Total Value

$276,385.99

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Jan 12, 2024

Avg Cost/Share

$53.50

Shares

8,000

Total Value

$427,999.20

Owned After

63,890

SEC Form 4

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

Sell
IONS Dec 26, 2023

Avg Cost/Share

$51.46

Shares

25,000

Total Value

$1,286,575.00

Owned After

63,890

SEC Form 4

Share on Social Networks: